Bond Clinic, PA

Winter Haven, Florida 33881

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Myelomonocytic Leukemia (CMML), Lymphoma, Diffuse Large B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, MPN (Myeloproliferative Neoplasms), Myelodysplastic Syndrome (MDS), NSCLC, Neutropenia

Studies at this site

• A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations — Paused
• Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study — Stopped early
• PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) — Completed
• Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer — Completed
• SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) — Completed
• Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) — Stopped early
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early
• Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL — Stopped early